EPLR 2/2021 (Vol. 5)

Editorial

Sabrina Röttger-Wirtz

Seite 69 - 70

‘No-one is Safe Until Everyone is Safe’ – Patent Waiver, Compulsory Licensing and COVID-19 open-access

Behrang Kianzad, Jakob Wested

Seite 71 - 91

Pharmaceutical Advertising in Digital Media: A Danish Perspective

Martin Dræbye Gantzhorn, Emil Bjerrum

Seite 92 - 97

Sponsoring a Clinical Trial: Pharmaceutical Companies’ Liability under the Scrutiny of the Italian Supreme Court

Elettra Gaspari

Seite 98 - 101

Does an Initially Authorised Combination Medicinal Product and a Later Authorised Single Component of that Combination Belong to the Same Global Marketing Authorization? - The Tecfidera® Judgment of the General Court in Case T-611/18

Guram Gobechia

Seite 102 - 105

Jurisdiction

Seite 106

New EU Pharmaceutical Law and Policy

Seite 107